Disease Info Card

Biliary Tract Neoplasm

Information about Biliary Tract Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Biliary Tract Neoplasm

Most recent studies have shown that Biliary Tract Neoplasm shares some biological mechanisms with adenocarcinoma, biliary-obstruction, biliary-tract-cancer, biliary-tract-diseases, carcinoma, cholangiocarcinoma, cholangitis, cholestasis, gallbladder-neoplasm, icterus, jaundice-obstructive, liver-neoplasms, malignant-neoplasm-of-gallbladder, malignant-neoplasm-of-pancreas, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, pancreatic-neoplasm, stenosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Biliary Tract Neoplasm, and have been seen in publications frequently: Aging, Angiogenesis, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Growth, Cell Proliferation, Coagulation, Dna Methylation, Enucleation, Excretion, Gastric Emptying, Induction Of Apoptosis, Liver Regeneration, Localization, Methylation, Pathogenesis, Regeneration, Secretion, Transport

Quite a number of genes have been found to play important roles in Biliary Tract Neoplasm, such as ALB, BTC, CCDC6, CDKN2A, CEACAM5, CEACAM7, EGFR, F9, HRAS, MID1, PGR, PSG2, PTCH1, RET, SMAD4, TAS2R38, TMEM37, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.